Conflicting data have been reported on cyclooxygenase (COX)-1 and COX-2 expression and activity in striated muscles, including skeletal muscles and myocardium, in particular it is still unclear whether muscle cells are able to produce prostaglandins.
Introduction
Prostanoids derive from arachidonic acid (AA) through the sequential enzymatic activity of cyclooxygenases (COX)-1 or -2, and of terminal synthases. Both COX-1 and -2 catalyze the conversion of AA into an unstable intermediate, the prostaglandin (PG) G/H 2 which is then transformed by distinct terminal synthases into PGE 2 , PGF 2 , thromboxane (TX) A 2, PGD 2 or PGI 2 .
COX-1 and COX-2, are encoded by different genes, are highly homologous and catalyze the same reaction, although they play different roles even within the same cell or tissue (28). The role of COX-1 or -2 and of different prostanoids in haemostasis, reproduction, kidney function, gastric protection and inflammation are well-known. TXA 2 is a vasoconstrictor and pro-aggregatory agent, PGI 2 is a vasodilating and endothelium-protective compound, and PGE 2 mediates inflammation (21). On the contrary, the possible presence and function of COX and prostanoids in striated muscles are less defined. More than 20 years ago Young and Sparks observed that skeletal muscles could release PGE 2 (35) and similar data were reported by Rodemann and Goldberg (22). Physical exercise has been shown to increase PGE 2 synthesis in normal muscles (10, 31, 32) . Elevated PGE 2 synthesis has been documented in muscles from patients with Duchenne muscular dystrophy or from mdx mice (9, 13) , as well as in regenerating skeletal muscles of rodents (12) . Nevertheless, it remains presently unknown whether muscle fibers or other cell types (fibroblasts, macrophages, cells of the vessel wall) account for PG release, and which COX isoform is present in striated muscles, both myocardial and skeletal. Furthermore, PGs function in the pathophysiology of muscle contraction, differentiation and regeneration, remains unclear.
We sought to characterize the pattern of expression of each COX isoform in striated muscles, including different skeletal muscles and myocardium, from three different species: mouse, rat and humans. Together with the expression, we also investigated the selective activity of each COX isoform as well as the effects of the major product of COX activity on rodent's muscle contraction.
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Materials and Methods
Tissue sampling
Skeletal muscles and hearts were obtained from adult Wistar rats (weighing 130-160 g) and adult CD1 mice (weighing 45-60g). Briefly, under deep anesthesia, animals were exsanguinated by carotid cutting and then killed by cervical dislocation. Heart, intact soleus and extensor digitorum longus (EDL) with short pieces of tendons were excised. Small biopsies of normal human skeletal muscles were obtained during orthopaedic surgery, after informed consent of patients. For mRNA studies, tissue samples were immediately frozen in liquid nitrogen and kept at -80°C until use. For immunohistochemistry, tissue samples were immediately mounted in OCT, frozen in liquid nitrogen and kept at -80°C until use or were immediately placed into buffered formalin, and then embedded in paraffin using standard procedures. Human heart samples were obtained from paraffinated samples of the Archives of the Pathology Department, originated from post-mortem hearts in subjects who died for non-cardiac causes. 
RNA preparation
Total RNA was isolated from frozen tissues by homogenization in Trizol Reagent (Life Technologies, Gaithersburg, MD) following the manufacturer's protocol. One µg of total RNA was reverse transcribed using Moloney murine leukemia virus (M-MLV) RT (GIBCO-Invitrogen, Carlsbad CA). PCR reactions were carried out by standard technique using Taq PCRx DNA Polymerase (GIBCO-Invitrogen, Carlsbad CA) under the following conditions: denaturation at 95°C for 30 sec, annealing at 50°C-55°C (for different amplifications) for 30 sec and extension at 68°C for 40 sec after the initial denaturation at 95°C for 2 min (35 cycles). The following 
Cyclooxygenase activity and inhibitor studies
Immediately after excision, soleus, EDL and small fragments of myocardium (15-20 mg) were washed twice in Krebs-Henseleit buffer (Sigma-Aldrich) to eliminate blood, and transferred to incubation chamber. Rat and mouse skeletal muscles were mounted and gently stretched to maintain them at 100% of their resting length. Every incubation was carried out in 1 ml of medium, equilibrated with 95% O 2 -5% CO 2 before use, and kept at 37°C under 95% O 2 -5% CO 2 throughout the experiment. All muscles were incubated following the same protocols.
To assess cyclooxygenase activity, skeletal muscles were subjected to 2 subsequent incubations of 30 min each. After the last incubation, the medium was removed and frozen for prostanoids measurements. In different experiments, skeletal muscles and myocardium were preincubated for 30 min with Krebs buffer, preincubation medium was then removed, and the same buffer with 20 µM AA was added for 30 min and the supernatants were frozen.
In experiments with COX inhibitors, samples were preincubated for 30 min with Krebs buffer containing 20 µM indomethacin (a non selective COX-1 and 2 inhibitor), 100 nM SC-560 (a selective COX-1 inhibitor), 100 nM NS-398 (a selective COX-2 inhibitor) (all from Cayman Chemicals, Ann Arbor MI), or vehicle; medium was then removed and the same buffer containing 20 µM AA and the correspondent inhibitor or vehicle were incubated for 30 min. At the end of any incubation, medium was collected and frozen for prostanoid measurements.
Determination of PGE 2 and TXB 2 PGE 2 and TXB 2 were determined in the medium of muscle incubation by using previously validated radioimmunoassays (2) .
Muscle contraction studies
Murine soleus and EDL muscles were dissected and transferred to the myograph, where they were mounted between the hook of a force transducer (AME 801; Aksjeselkapet Mikkroelektronik, Norway) and a hook connected to a movable shaft used to adjust muscle length. Muscles were tied to the hooks by means of silk threads that had been previously fixed to the tendons. 
Statistical analysis
Values are reported as means±1 standard deviation (SD) or standard error (SE), as indicated.
Statistical significance of the differences between means was assessed by analysis of variance followed by the Student-Newman-Keuls test or by Student's t-test for paired or non-paired data, as indicated. Statistical significance was set at P<0.05.
Results
Cyclooxygenase expression and activity in skeletal muscles
Messenger RNAs for COX-1 and COX-2 were detected in samples from different muscle types of mice, rats and humans ( Figure 1) . Consistently, Western blots showed immunoreactive COX-1 and COX-2 of the expected size (i.e. approx. 70 kD) in muscle homogenates from rat, mouse and human samples (Figure 2 A, B) . Densitometric analysis of the western-blot bands, expressed as ratios of COX-1 or -2 versus tubulin bands showed no major differences in levels of protein expression among different types of muscles within the same species, including predominantly slow (soleus), fast (EDL, tibialis anterior) or mixed (diaphragm, rectus abdominis)
To identify the cells expressing COX isoenzymes, samples of skeletal muscles were studied by immunohistochemistry using specific antibodies. COX-1 and COX-2 immunoreactivity was consistently observed in muscle fibers of rodents ( Figure 3 were positives for COX-1 and COX-2. This pattern was consistent among all different species. We studied different types of muscles, and the expression of both COX-1 and -2 protein was similar.
To further assess whether COX isoenzyme had any preferential expression in different types of fibers, serial sections of rodent and human muscles were stained with antibodies specific for type I Figure 6 ). The amounts of PGE 2 released by rat and mouse muscles were 4-5 times higher in the presence of AA loaded to the medium (rat EDL: 10.3±3.6 vs. 1.4±0.6 pg/mg muscle, with and without AA, respectively, n=4; mouse soleus: 43±14 vs. 13±9 pg/mg muscle, with and without AA, respectively, n=4). The predominance of PGE 2 indirectly demonstrated that muscle specimens were properly washed and depleted of blood and platelets, being TXA 2 the main platelet-derived product instead (21). The amount of PGE 2 released from mouse soleus and EDL, normalized for muscle's weight, was 5-8 times higher than that released from rat muscles ( Figure 6 ). This difference might be attributed to the different thickness of the muscles in the two species. Taking into account the size of the rat muscles, it is likely that not the whole muscles, but only the outer layers of the muscles could release the prostanoid into the incubation medium.
To discriminate the relative contribution of each COX isoform to PGE 2 formation, muscle samples were pre-incubated with the non-selective inhibitor indomethacin or with the COX-1-selective inhibitor SC-560 or with the COX-2-selective inhibitor NS-398. Among the three different inhibitors, indomethacin (20 µM) showed the higher degree of inhibition of PGE 2 in both species and in all the muscles examined, as shown in figure 6 . At variance with indomethacin, SC-560 and NS-398 at concentrations known to be isoform-selective such as 100 nM, caused a lower degree of inhibition of PGE 2 synthesis. Dose response experiments showed similar degrees of inhibition between 100 nM and 1 µM of both SC-560 and NS-398, indicating that each isoform was maximally inhibited at those concentrations (data not shown). We did not check concentrations higher than 1 µM, because drug selectivity is lost by increasing the concentrations (20). These experiments indicate that both COX isoforms are enzymatically active and contribute to PGE 2 synthesis in rodents, although COX-1 inhibition consistently gave higher degree of PGE 2 reduction as compared to COX-2 inhibition ( Figure 6 ).
In vitro effects of exogenous PGE 2 on muscle contraction
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The effects of PGE 2 on the time and tension parameters of the isometric twitch were investigated in vitro in both murine soleus and EDL. No effects on active tension and on time to peak tension were detected at concentrations up to 10 µM. However, PGE 2 induced a small, but significant reduction in the half relaxation time, that was evident in the slow-muscle-type, i.e. the soleus, rather than in the EDL (Figure 7 ).
Cyclooxygenase expression and activity in the myocardium
Myocardial samples from mouse and rat expressed mRNA and protein of both COX-1 and - pg/mg of tissue of PGE 2 , respectively (n=6 for each species) in 30 minutes incubation. Thus, similar amounts of PGE 2 were released from fragments of mouse and rat myocardium.
In rat samples, SC-560 (100 nM) lowered the amount of PGE 2 released in 30 minutes to 6.4±3.4 pg/mg of tissue, corresponding to a 80% inhibition (p<0.05), while NS-398 (100nM) reduced the production to 12.2±4.4 pg/mg of tissue, corresponding to a 63% inhibition (p<0.05). In mouse samples SC-560 significantly inhibited PGE 2 release by 59% on average, while NS-398 caused an average 80% inhibition. These data, showing that each selective COX inhibitor caused an incomplete inhibition of PGE 2 production from heart muscle, indicate that both isoforms are enzymatically active and contribute to PGE 2 generation in the myocardium.
Discussion
The present study demonstrates a constitutive expression of both COX-1 and COX-2 in different types of muscles fibers and in cardiomyocytes of three different species. At least in rodents, COX isozymes are enzymatically active, being inhibited by COX-1 or -2 selective blockers. Furthermore, in the murine soleus, which is a slow type of muscle, PGE 2 in the low micromolar range made relaxation significantly faster.
Whereas COX expression or PG generation has been previously described during myogenesis and skeletal muscle regeneration, more limited information is available on the role of PGs in adult skeletal muscle physiology and on the expression in skeletal muscle fibers of the enzymes responsible for PGs production. More than 20 years ago Rodemann and coworkers suggested a role for exogenous PGE 2 and PGF 2 in the acceleration of muscle protein turnover (22, 23), well before the discovery of COX-2. A generic role for COX-derived compounds on protein metabolism in skeletal muscle has also been hypothesized by some Authors to explain the analgesic effect of ibuprofen and acetaminophen after eccentric exercise in humans, without characterizing the expression and the type of COX isoenzymes involved (31, 32) . A role for PGs in muscle cell fusion and growth in different animal species has also been reported (38, 4, 29, 6, 14, 24, 33, 17) .
More recently, it has been reported that COX-2 is required during mouse skeletal muscle regeneration after different models of injury, using selective COX-2 inhibitors and/or COX-2-deleted mice (1, 27, 5), although none of those studies assessed the type of prostaglandin involved. No data are available on a possible role of PGE 2 on skeletal muscle contraction. Our data show a modest reduction of half relaxation time induced by PGE 2 in the low micromolar range in the slow soleus muscle, while no effect was observed in the fast EDL muscle. This diversity could be explained by the difference among the slow and fast muscle fibers in controlling cytosolic calcium. Slow muscle fibers share with cardiac and smooth muscle, although to a limited extent, the regulation of sarcoplasmic reticulum calcium pump via phospholamban (34) and the involvement of transarcolemmal calcium movements in the transient increase which accompanies contraction (19, 8) . Further study will clarify the physiological relevance.
Our data showed that cardiomyocytes also express enzymatically-active COX-1 and -2 in to fully-differentiated adult cells. It would be interesting to explore which is the trigger in the heart for a physiological constitutive COX-2 expression in cardiomyocytes. The report of a constitutive expression of COX-2 in human cardiomyocytes is quite novel. Although we recognize that our observations are on post-mortem tissues being the collection of fresh and healthy myocardium unethical, however, the consistency of a constitutive expression of COX-2 among three different species, indirectly supports the likelihood of our finding in living human hearts as well. Wong et al described a strong expression of COX-2 in failing human hearts, but found no expression in control hearts (36) . This discrepancy might be due to different sources of antibodies used in Wong's and in our experiments. On the contrary, our data are in agreement with Liu and coworkers who found a constitutive expression of both COX-1 and -2 in rat hearts, and this expression was enhanced by lipopolysaccharide infused in vivo (11) . We report that PGE 2 was the main prostaglandin released by rodent's hearts via COX-1 and COX-2. The prevalence of PGE 2 is consistent with data reported in vitro in cultured neonatal rat cardiomyocytes (16) .
In conclusion, the present study demonstrates that COX isozymes are both expressed and enzymatically active in striated muscles, both in myocardial and skeletal muscles. The predominant prostaglandin produced in PGE 2 . Our data also suggest a modulation of slow skeletal muscles relaxation by PGE 2 . 
